|
CREB3L1–EWSR1
(HGNC:18856, HGNC:3508)
|
MONDO:0012817
(MONDO:0012817)
|
strong |
moderate |
strong |
strong |
weak |
|
|
CREB3L1–FUS
(HGNC:18856, HGNC:4010)
|
MONDO:0006272
(MONDO:0006272)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
CCDC6–KIF5B
(HGNC:18782, HGNC:6324)
|
MONDO:0005233
(MONDO:0005233)
|
weak |
weak |
weak |
weak |
weak |
|
|
SLC44A1–PRKCA
(HGNC:18798, HGNC:9393)
|
papillary glioneuronal tumor
(MONDO_0016735)
|
strong |
moderate |
weak |
strong |
weak |
|
|
CCNB3–BCOR
(HGNC:18709, HGNC:20893)
|
MONDO:0958160
(MONDO:0958160)
|
strong |
strong |
moderate |
strong |
weak |
|
|
CCDC6–RET
(HGNC:18782, HGNC:9967)
|
MONDO:0005075
(MONDO:0005075)
|
strong |
strong |
moderate |
strong |
weak |
|
|
CCDC6–NCOA4
(HGNC:18782, HGNC:7671)
|
thyroid gland papillary carcinoma
(MONDO_0005075)
|
weak |
weak |
weak |
weak |
weak |
|
|
CNTRL–FGFR1
(HGNC:1858, HGNC:3688)
|
MONDO:0013296
(MONDO:0013296)
|
strong |
strong |
moderate |
strong |
weak |
|
|
YPEL5–PPP1CB
(HGNC:18329, HGNC:9282)
|
B-cell chronic lymphocytic leukemia
(MONDO_0004948)
|
moderate |
weak |
weak |
weak |
weak |
|
|
FEV–EWSR1
(HGNC:18562, HGNC:3508)
|
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
CEBPE–IGH
(HGNC:1836, HGNC:5477)
|
B-cell acute lymphoblastic leukemia
(MONDO_0004947)
|
moderate |
weak |
weak |
strong |
weak |
|
|
RAB40B–PML
(HGNC:18284, HGNC:9113)
|
MONDO:0012883
(MONDO:0012883)
|
weak |
weak |
weak |
weak |
weak |
|
|
KHDRBS1–NTRK3
(HGNC:18116, HGNC:8033)
|
pediatric angiosarcoma
(MONDO_0003022)
|
moderate |
strong |
moderate |
moderate |
weak |
|
|
WIF1–HMGA2
(HGNC:18081, HGNC:5009)
|
pleomorphic adenoma
(MONDO_0008401)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
CDX2–ETV6
(HGNC:1806, HGNC:3495)
|
leukemia
(MONDO_0005059)
|
strong |
weak |
moderate |
strong |
weak |
|
|
CDK4–MDM2
(HGNC:1773, HGNC:6973)
|
MONDO:0020563
(MONDO:0020563)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
CD274–PDCD1LG2
(HGNC:17635, HGNC:18731)
|
head and neck squamous cell carcinoma
(MONDO_0010150)
|
weak |
weak |
moderate |
weak |
weak |
|
|
KAT6B–KANSL1
(HGNC:17582, HGNC:24565)
|
uterine corpus leiomyoma
(MONDO_0007886)
|
strong |
weak |
moderate |
strong |
weak |
|
|
JAZF1–SUZ12
(HGNC:28917, HGNC:17101)
|
MONDO:0003311
(MONDO:0003311)
|
strong |
weak |
moderate |
strong |
weak |
|
|
TAF3–MN1
(HGNC:17303, HGNC:7180)
|
|
moderate |
weak |
moderate |
moderate |
weak |
|